Tyler-Stone Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-70
Closed -$7K 963
2023
Q3
$7K Sell
70
-55
-44% -$6.2K ﹤0.01% 662
2023
Q2
$16K Buy
+125
New +$15.1K 0.01% 515

Other funds holding DXCM

Tyler-Stone Wealth Management's DXCM Position: Q4 2023 in Review

Tyler-Stone Wealth Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 70 shares — an estimated $7K sold.

Tyler-Stone Wealth Management first reported a position in DXCM in Q2 2023 and held it in 2 quarters. The position peaked at $16K in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Tyler-Stone Wealth Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 70 DexCom shares in Q4 2023, an estimated $7K.
  • Tyler-Stone Wealth Management first reported a position in DexCom in Q2 2023 and held it in 2 quarters.
  • Tyler-Stone Wealth Management's DexCom position peaked at $16K in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Tyler-Stone Wealth Management's 13F filing for Q4 2023, filed 14 Feb 2024.